By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Affimed Therapeutics AG 

Im Neuenheimer Feld 582
Heidelberg    69120   Germany
Phone: 49-6221-65307-0 Fax: 49-6221-65307-77



Company News
Affimed (AFMD) Presents Data On First-In-Class BCMA-Targeting Immune Cell Engager AFM26 At ASCO Annual Meeting 2017 6/6/2017 8:28:58 AM
Affimed (AFMD) Announces Annual General Meeting Of Shareholders 5/22/2017 8:04:38 AM
Affimed (AFMD) Reports Financial Results For First Quarter 2017 5/17/2017 10:59:10 AM
Affimed (AFMD) Announces First Quarter 2017 Financial Results And Corporate Update Conference Call 5/10/2017 12:02:16 PM
Affimed (AFMD) Release: Biopharma Announces Proposed Public Offering Of Common Stock 1/20/2017 7:07:20 AM
Affimed (AFMD) Release: Biopharma Provides Update On NK-Cell Immuno-Oncology Platform 1/11/2017 7:15:49 AM
Affimed (AFMD) To Present At Upcoming Investor Conferences 9/1/2016 8:00:54 AM
Affimed (AFMD) Announces Annual General Meeting Of Shareholders 5/24/2016 8:15:39 AM
Affimed (AFMD) To Present At The UBS Global Healthcare Conference -- New York 5/17/2016 10:05:35 AM
Affimed (AFMD) Presents Data On EGFRwt and EGFRvIII-Targeting NK- And T-Cell Tandabs At The AACR Annual Meeting 2016 4/21/2016 8:31:50 AM